Ventas, Inc. (NYSE:VTR)

CAPS Rating: 5 out of 5

The Company is a healthcare real estate investment trust with a geographically diverse portfolio of seniors housing and healthcare-related properties in the United States.

VTR News and Commentary

Caps

How do you think VTR will perform against the market?

Add Stock to CAPS Watchlist

All Players

243 Outperform
37 Underperform
 

All-Star Players

46 Outperform
13 Underperform
 

Wall Street

8 Outperform
1 Underperform
 

Top VTR Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

InvestorDeb (68.46)
Submitted October 12, 2017

Ventas (NYSE:VTR) is a REIT specializing in healthcare properties.The company owns more than 1,200 properties, and the majority of these (55%) are senior housing. Medical offices, post-acute care properties, life science facilities, and health system… More

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

VTR VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about VTR.

Recs

0
Member Avatar TMFReubenGBrewer (44.70) Submitted: 4/5/2018 11:19:13 AM : Outperform Start Price: $49.68 VTR Score: +8.94

Healthcare REIT that's out of favor right now because of a near-term supply imbalance in senior housing. Demographics should solve that problem over time. While waiting, investors can collect a fat dividend yield.

Recs

0
Member Avatar MFlyhauser (< 20) Submitted: 1/29/2018 3:12:15 PM : Underperform Start Price: $54.74 VTR Score: -5.55

Estimate flat FFO growth - great dividend, 75% payout, as long as it does not get cut

Recs

1
Member Avatar InvestorDeb (68.46) Submitted: 10/12/2017 1:19:57 PM : Outperform Start Price: $61.09 VTR Score: -16.58

Ventas (NYSE:VTR) is a REIT specializing in healthcare properties.

The company owns more than 1,200 properties, and the majority of these (55%) are senior housing. Medical offices, post-acute care properties, life science facilities, and health system real estate make up the rest.

There are two major growth opportunities that Ventas could capitalize on. First, there's the ongoing retirement of the baby boomer generation. The 75-and-older age group in the U.S. is growing seven times as fast as the overall population, and is expected to increase by 70% by 2030. This should translate to steadily growing healthcare demand, especially in the senior housing industry, Ventas' bread-and-butter.

In addition, the existing healthcare real estate market is more than $1 trillion in size, and is less than 15% REIT-owned. This is significantly lower than many other types of commercial real estate, and means that there is lots of opportunity for consolidation.

Ventas has grown its funds from operations (the REIT version of earnings) at an 11% annualized rate since 2001, and has been able to safely increase its dividend at a faster rate than its peers. So, not only is Ventas a high-income stock with a safe 4.9% yield, but it has the capability to generate market-beating returns as well.

This is a new holding in my Roth IRA, so only 25% of a full position now...

Leaderboard

Find the members with the highest scoring picks in VTR.

Score Leader

XMFHelical

XMFHelical (< 20) Score: +173.05

The Score Leader is the player with the highest score across all their picks in VTR.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
stormraven 21.21 7/30/2007 Outperform NS $16.63 +234.84% +98.18% +136.66 0 Comment
ahrahr < 20 11/20/2008 10/25/2017 Outperform 5Y $11.23 +395.92% +259.67% +136.24 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. woodruffdavid 50.64 7/30/2007 Outperform 5Y $16.77 +232.00% +96.70% +135.31 2 Comments
Gronkt 48.42 11/18/2008 Outperform 3Y $12.09 +360.57% +230.82% +129.74 0 Comment
Sand105 20.72 7/31/2007 Outperform 3Y $17.21 +223.60% +94.98% +128.62 1 Comment
rebelle1 < 20 7/26/2007 Outperform NS $17.37 +220.56% +96.03% +124.53 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. otsc257 84.40 8/9/2007 Outperform NS $17.56 +217.21% +96.16% +121.04 0 Comment
manjani 67.89 8/9/2007 Outperform NS $17.56 +217.21% +96.16% +121.04 0 Comment
alanwledford 59.62 6/19/2007 Outperform 5Y $19.59 +184.30% +89.05% +95.25 0 Comment
markwargo 61.66 7/23/2007 Outperform 3Y $19.86 +180.47% +87.57% +92.90 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackBMOCapital < 20 7/27/2015 Outperform NS $50.42 +10.45% +32.76% -22.32 0 Comment
TrackEvercorePar 52.71 10/6/2014 Outperform NS $46.48 +19.81% +39.22% -19.41 0 Comment
trackmizuho < 20 7/23/2014 Outperform NS $47.31 +17.72% +38.41% -20.69 0 Comment
TrackBMOCapital < 20 1/2/2014 Underperform NS $53.29 +24.77% +12.58% -12.19 7/27/2015 @ $66.49 0 Comment
TrackMacquarie 95.22 1/10/2013 Underperform NS $44.40 +25.43% +87.24% +61.81 0 Comment
TrackJimCramer 85.44 6/27/2012 Outperform 3W $40.96 +35.95% +106.30% -70.36 0 Comment
TrackZacks < 20 12/22/2011 Outperform 3M $54.51 +2.73% +9.31% -6.57 2/24/2012 @ $56.00 1 Comment
TrackZacks < 20 8/4/2011 Outperform 3M $48.06 +7.17% +0.72% +6.45 10/19/2011 @ $51.51 1 Comment
TrackZacks < 20 5/13/2011 Outperform 3M $54.15 +2.16% +0.24% +1.92 5/18/2011 @ $55.32 1 Comment
TrackStifel 93.94 5/11/2011 Outperform NS $54.72 -2.98% -8.61% +5.63 10/25/2011 @ $53.09 0 Comment
TrackZacks < 20 9/30/2010 Outperform 3M $51.01 +8.88% +17.63% -8.75 2/17/2011 @ $55.54 1 Comment
TrackRWBaird 90.63 3/18/2010 Underperform NS $45.42 +22.32% +15.26% -7.06 5/13/2011 @ $55.56 0 Comment
TrackStifel 93.94 11/17/2009 Outperform NS $40.77 +17.79% +5.54% +12.25 3/23/2010 @ $48.02 0 Comment
TrackMorganKeeg 78.05 7/7/2009 Outperform NS $17.56 +217.13% +207.72% +9.41 0 Comment
TrackUBS 92.06 11/14/2008 Outperform NS $26.53 +15.25% +2.96% +12.28 1/5/2009 @ $30.57 0 Comment
TrackStifel 93.94 10/20/2008 Outperform NS $35.22 -1.27% +3.90% -5.17 7/31/2009 @ $34.77 0 Comment
TrackChrisDavis 91.67 6/3/2008 Outperform 1Y $26.04 +113.90% +104.53% +9.36 1 Comment
TrackHeebner < 20 12/31/2007 Outperform NS $38.22 +18.97% -30.45% +49.42 6/30/2010 @ $45.47 3 Comments
TrackDreman 38.07 9/30/2007 Outperform NS $22.00 +153.10% +88.66% +64.45 2 Comments
TrackStifel 93.94 9/18/2007 Outperform NS $39.15 +16.39% -9.24% +25.63 4/10/2008 @ $45.57 0 Comment
TrackMorganKeeg 78.05 4/5/2007 Outperform NS $42.10 +13.36% -0.76% +14.12 5/16/2008 @ $47.72 0 Comment
TrackBofASec 93.99 12/20/2006 Outperform NS $21.41 +160.06% +104.93% +55.14 0 Comment
TrackStifel 93.94 11/28/2006 Outperform NS $37.29 +5.52% +8.22% -2.70 6/8/2007 @ $39.35 0 Comment
TrackKeyBanc 96.06 10/24/2006 Outperform NS $32.62 +46.15% -14.47% +60.62 3/25/2010 @ $47.67 0 Comment
TrackUBS 92.06 10/10/2006 Outperform NS $36.38 +21.62% +15.17% +6.45 10/9/2007 @ $44.25 0 Comment
TrackRyanBeck < 20 8/30/2006 Outperform NS $32.14 +15.87% -0.40% +16.27 3/1/2007 @ $37.24 0 Comment

Featured Broker Partners


Advertisement